Altimmune (ALT) Price to FCF (2017 - 2026)
Powered by 
Analysis
Altimmune (ALT) Price to FCF (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Altimmune | 616.60 Mn | 616.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.38 |
| Mar 31, 2026 | -19.13 |
| Dec 31, 2025 | -16.35 |
| Sep 30, 2025 | -30.29 |
| Jun 30, 2025 | -17.02 |
| Mar 31, 2025 | -23.11 |
| Dec 31, 2024 | -28.56 |
| Sep 30, 2024 | -16.10 |
| Jun 30, 2024 | -26.09 |
| Mar 31, 2024 | -44.13 |
| Dec 31, 2023 | -36.23 |
| Sep 30, 2023 | -6.71 |
| Jun 30, 2023 | -9.59 |
| Mar 31, 2023 | -10.69 |
| Dec 31, 2022 | -46.66 |
| Sep 30, 2022 | -41.55 |
| Jun 30, 2022 | -32.44 |
| Mar 31, 2022 | -19.45 |
| Dec 31, 2021 | -16.98 |
| Sep 30, 2021 | -25.16 |